TAGRISSO – Osimertinib uses, dose and side effects
TAGRISSO contains the active substance osimertinib, which belongs to a group of medicines called protein kinase inhibitors and is used to treat cancer. TAGRISSO is used to treat adults with a type of lung cancer called non- small cell lung cancer . If a test has shown that your cancer has certain changes ( mutations ) in the gene “EGFR” ( epidermal growth factor receptor), your cancer will likely respond to treatment with TAGRISSO. TAGRISSO can be prescribed:
Read More